DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo

Synageva BioPharma (NASDAQ: GEVA)

120.45 5.13 (4.45%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GEVA $120.45 4.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $115.82
Previous Close $115.32
Daily Range $115.00 - $120.75
52-Week Range $60.19 - $122.88
Market Cap $4.0B
P/E Ratio -22.31
Dividend (Yield) $0.00 (0.0%)
Volume 296,368
Average Daily Volume 354,165
Current FY EPS -$5.84

Sector

Healthcare

Industry

Drugs

Synageva BioPharma (GEVA) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of a new class of antiviral drug treatments called fusion inhibitors. Website: http://www.synageva.com/

News & Commentary

3 Biotech Stocks Focused on Curing Ultra-Rare Diseases

Three biotech stocks are taking the path less traveled by focusing their drug development pipelines on treating ultra-rare diseases.

Synageva Starts Dosing in Phase I/II Study for Sanfilippo B - Analyst Blog

Synageva BioPharma Announces Dosing Of Patients Commenced With SBC-103 In Phase 1/2 Study For Mucopo

Synageva BioPharma Announces Dosing Of Patients Commenced With SBC-103 In Phase 1/2 Study For Mucopolysaccharidosis IIIB And FDA Fast Track Designation Granted

Insiders Bullish On Certain Holdings Of TWOK

Why You Shouldn't Bet Against Synageva BioPharma (GEVA) Stock - Tale of the Tape

Use Options For a Chance To Buy GEVA at a 25% Discount

4 More Biotech Secondaries Investors Are Watching

Benzinga's Volume Movers

Synageva BioPharma (GEVA) Moving On Heavy Volume In The Pre-Market Hours

Can The Uptrend Continue for Synageva Biopharma (GEVA)? - Tale of the Tape

See More GEVA News...

GEVA's Top Competitors

GEVA $120.45 (4.45%)
Current stock: GEVA
AMGN $156.37 (1.12%)
Current stock: AMGN
GILD $104.15 (1.66%)
Current stock: GILD
BIIB $353.25 (0.59%)
Current stock: BIIB